Abraham Ceesay's Net Worth

$2.06 Million

Estimate Recalculated Nov 8, 2024 09:41PM EST

Who is Abraham Ceesay

Abraham Ceesay has an estimated net worth of $2.06 Million. This is based on reported shares across multiple companies, which include Cerevel Therapeutics Holdings, Inc., scPharmaceuticals Inc., Pacira BioSciences, Inc., and Rapport Therapeutics, Inc..

SEC CIK

Abraham Ceesay's CIK is 0001722140

Past Insider Trading and Trends

2022 was Abraham Ceesay's most active year for acquiring shares with 6 total transactions. Abraham Ceesay's most active month to acquire stocks was the month of May. 2022 was Abraham Ceesay's most active year for disposing of shares, totalling 11 transactions. Abraham Ceesay's most active month to dispose stocks was the month of July. 2022 saw Abraham Ceesay paying a total of $1,265,057.52 for 216,366 shares, this is the most they've acquired in one year. In 2022 Abraham Ceesay cashed out on 192,112 shares for a total of $3,255,048.22, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Cerevel Therapeutics Holdings, Inc.

President
Updated Feb 08, 2023
Form 4
143.53K
Feb 08, 2023
143.53K
Grant
Feb 06
Form 4
-5.00%
-19.21K
$22.84
-$371.33K
Sep 12, 2022
365.01K
Sale
ScheduledSep 08
Form 4
-2.44%
-9.61K
$22.84
-$185.66K
Aug 24, 2022
384.22K
Sale
ScheduledAug 22
Form 4
-2.38%
-9.61K
$23.65
-$201.25K
Aug 17, 2022
393.82K
Sale
ScheduledAug 15
Form 4
-12.50%
-57.63K
$23.86
-$1.23M
Aug 09, 2022
403.43K
Sale
ScheduledAug 05 - Aug 08
Form 4
120.31K
Feb 11, 2022
120.31K
Grant
Feb 09
Form 4
461.06K
Jun 03, 2021
461.07K
Grant
Jun 01
Form 3
May 13, 2021
Showing 8 results

scPharmaceuticals Inc.

Chief Operating Officer
Updated Jan 19, 2018
Form 4
80.97K
Jan 19, 2018
80.97K
Grant
Jan 17
Form 3
Nov 16, 2017
Showing 2 results

Pacira BioSciences, Inc.

Investor
Updated Jun 13, 2024
Form 4
17.41K
Jun 13, 2024
17.41K
Grant
Jun 12
Form 4
30.97K
Oct 11, 2023
30.97K
Grant
Oct 06
Form 3
Oct 11, 2023
Showing 3 results

Rapport Therapeutics, Inc.

Chief Executive Officer
Updated Jun 10, 2024
Form 4
530.65K
Jun 10, 2024
530.65K
Grant
Jun 06
Form 3
Jun 06, 2024
789.71K
Showing 2 results